Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q ® (epinephrine injection, USP) ...

Glen Allen, VA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-device combinations and auto-injector innovation, recognizes its 25th anniversary by celebrating the people, purpose, ...

BRIDGEWATER, N.J. (CN) - Sanofi US announced Thursday that it is voluntarily recalling all Auvi-Q epinephrine injections it sells to treat allergic reactions. Sanofi warns that accurate dosages of ...

Read full article: Winter Weather Advisory issued for Metro Detroit Read full article: Teenager charged with making terroristic threats toward Ann Arbor elementary school Police are seeking ...

Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection, USP) ...

AUVI-Q (R) (epinephrine injection, USP) is still available by prescription for children with life-threatening allergies. Most kids spend the final weeks of summer amassing school supplies and cramming ...

BRIDGEWATER, N.J. (AP) – Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the life-saving ...

Auvi-Q (epinephrine) is a brand-name injectable drug. It’s prescribed for emergency treatment of severe allergic reactions. Auvi-Q has interactions with some other drugs, including diuretics and ...

AUVI-Q is a prescription medicine approved by the FDA to treat emergency allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions.

BRIDGEWATER, N.J., Oct. 28, 2015 /PRNewswire/ -- Sanofi US is voluntarily recalling all Auvi-Q ® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both ...